John Sununu's Financial Gains Amid Rising Prices in Key Sectors
Financial Gains for John Sununu from Rising Consumer Costs
As John Sununu campaigns for a return to the U.S. Senate, financial disclosures reveal that he has gained significantly from inflation in key areas such as gas, food, and medicine. This coincides with his focus on affordability issues that are currently pressing for New Hampshire voters.
Sununu, a former senator from 2003 to 2009, boasts a substantial net worth, which is estimated to be as high as $36.3 million. His financial success has been bolstered by significant investments in sectors that are experiencing price surges due to various global events, including tariffs and ongoing conflicts.
Gas Prices and Oil Investments
Sununu has made substantial investments in the oil and gas sector, specifically benefiting from the ongoing disruptions caused by the conflict with Iran. These disruptions have led to increased gas prices, benefiting his investments in companies like ExxonMobil and Shell, with holdings estimated between $50,000 to $65,000. The value of these investments has reportedly increased by about 24% as gas prices climb in New Hampshire (source).
Despite the mixed opinions surrounding the Iran conflict, Sununu has voiced his support for the military actions, arguing their importance for national and economic security during appearances on platforms like New Hampshire Today.
Investments in Grocery Sector
In addition to oil, Sununu holds noteworthy investments in the food industry, including up to $150,000 in Wal-Mart and sizable stakes in PepsiCo and Coca-Cola, both estimated at $100,000 each. The rise in grocery prices, attributed to increased shipping expenses and tariffs, has resulted in a projected increase in the value of these stocks. The Bureau of Labor Statistics noted a 2.4% rise in food prices throughout 2025, fueled by the tariffs introduced under President Donald Trump (source). Consequently, Sununu’s investments in these companies have realized growth rates of 4%, 34%, and 21% respectively, amounting to a combined increase of at least $50,000.
Despite the public outcry regarding the effects of these tariffs, Sununu has described their economic impact as "very modest" and has dismissed rulings against them while maintaining that the executive branch still holds the power to impose alternative tariffs.
Connections to Pharmaceutical Industry
Sununu's investment portfolio also extends into the pharmaceutical industry, with significant holdings totaling as much as $425,000 in major players like Pfizer and Merck. This comes at a time when there have been discussions at the White House regarding lowering drug prices, yet many pharmaceuticals have continued price increases, including a notable 15% rise for Pfizer's COVID vaccine.
During his previous Senate tenure, Sununu consistently opposed legislation aimed at reducing drug costs, including efforts to enable Medicare negotiations and the importation of cheaper drugs from Canada. He further enhanced his connections to the pharmaceutical industry through his subsequent work as a lobbyist for Akin Gump, which involved representing companies such as Pfizer and Merck.
As Sununu gears up for the upcoming primary on September 8 against former Massachusetts Senator Scott Brown, the outcome will position the winner to face off against Democratic Representative Chris Pappas in the November elections.